The 2025 Nobel Prize in Medicine: How Treg and FOXP3 Discoveries Transform Autoimmunity, Cancer, and Transplant Therapies

Discover how the 2025 Nobel Prize in Medicine for Treg and FOXP3 research is revolutionizing treatments for autoimmunity, cancer, and transplants.

The 2025 Nobel Prize in Medicine – What Benefits Will Our Patients Gain?

Adrian Hunis, MD
School of Medicine, University of Buenos Aires (UBA)
This email address is being protected from spambots. You need JavaScript enabled to view it.

Shimon Sakaguchi  Osaka University, Osaka, Japan	Fred Ramsdell Sonoma Biotherapeutics, San Francisco, USA	Mary E. Brunkow Institute for Systems Biology, Seattle, USA

Abstract

In 2025, Mary E. Brunkow, Fred J. Ramsdell, and Shimon Sakaguchi received the Nobel Prize in Physiology or Medicine for fundamental discoveries in peripheral immune tolerance: the identification of regulatory T cells (Treg) and the pivotal role of the FOXP3 transcription factor in their identity and function. These findings explain how the immune system avoids self-damage while preserving defense capabilities, offering therapeutic opportunities in autoimmunity, transplantation, and oncology.

Introduction

Since its inception in 1901, the Nobel Prize in Physiology or Medicine, awarded by the Nobel Assembly at the Karolinska Institute, has honored discoveries that advance the health and welfare of humankind. The 2025 award continues this tradition, recognizing milestones in immunology that span from phagocytosis and the MHC to innate immunity and immune checkpoints. The discovery of Treg and FOXP3 represents a paradigm shift in understanding immune tolerance and its therapeutic translation.

Profiles of the Laureates

• Shimon Sakaguchi (Japan): In 1995, he identified a CD4+CD25+ T cell subpopulation with regulatory function maintaining self-tolerance, and linked FOXP3 to Treg lineage commitment, establishing the field of peripheral tolerance.

• Mary E. Brunkow (USA): In 2001, she linked mutations of the Foxp3 (scurfy) gene to lethal autoimmunity in mice, providing the genetic foundation for Treg function and the human correlation with IPEX syndrome.

• Fred J. Ramsdell (USA): Co-discoverer of FOXP3’s essential role in immune homeostasis and Treg biology, with translational leadership toward Treg-based therapies.

Results and Mechanistic Insights

Regulatory T cells (CD4+CD25+FOXP3+) suppress effector immune responses through diverse mechanisms: competitive IL‑2 consumption (via high CD25 expression), secretion of immunoregulatory cytokines (IL‑10, TGF‑β, IL‑35), cell–cell contact (CTLA‑4, TIGIT, PD‑1), metabolic control (CD39/CD73→adenosine), targeted cytotoxicity, and reprogramming of antigen-presenting cells. Defective number or function of Treg leads to autoimmunity, while FOXP3 mutations cause IPEX syndrome.

Table 1. Mechanisms of Action of Treg and Pharmacological Targets

Table 2. Diseases Associated with Treg Dysfunction and Therapeutic Rationale

Table 3. Treg-Based Therapeutic Modalities and Development Status

Future Perspectives

Future priorities include antigen-specific Treg engineering, biomarker development (FOXP3 TSDR, in vivo tracers), scalable ATMP manufacturing, rational combinations with ICI/JAK inhibitors, characterization of tissue and CD8+ Treg subsets, patient stratification, and long-term safety assessment.

Conclusions

The 2025 Nobel Prize in Medicine recognizes a paradigm shift: peripheral tolerance mediated by Treg/FOXP3 as a cornerstone of immune homeostasis. Therapeutic translation through IL‑2 bias, adoptive Treg transfer, and selective modulators already demonstrates efficacy signals in autoimmunity and transplantation, and emerging oncology strategies to modulate Treg contextually. Clinical consolidation will depend on robust biomarkers and indication-specific designs.

References

1. NobelPrize.org. The Nobel Prize in Physiology or Medicine 2025 – Press Release. 2025 Oct 6.
2. NobelPrize.org. Scientific Background to the Nobel Prize in Physiology or Medicine 2025. 2025.
3. Brunkow ME, et al. Nat Genet. 2001;27(1):68–73.
4. Sakaguchi S, et al. J Immunol. 1995;155(3):1151–64.
5. NobelPrize.org. Popular Information: They Understood How the Immune System is Kept in Check. 2025.
6. Sakaguchi S. Curr Opin Immunol. 2007;19(6):667–73.
7. Bennett CL, et al. Nat Genet. 2001;27(1):20–1.
8. Rudensky AY, et al. Nat Rev Immunol. 2011;11(11):845–52.
9. UCLA Health Newsroom. Fred Ramsdell wins 2025 Nobel Prize in Physiology or Medicine. 2025 Oct 6.
10. Shan F, et al. Cancers (Basel). 2022;14(19):4660.
11. Rosenzwajg M, et al. Ann Med. 2019;51(2):133–44.